![](https://ml.globenewswire.com/media/2465395d-8e05-4881-acd8-00ab656e8115/small/scpharmaceuticals-logo-4c-new-jpg.jpg)
scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX ...
BURLINGTON, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, …